Trapezius Port Placement in Patients with Breast Cancer: Long-Term Follow-up and Quality-of-Life Assessment.
Adult
Aged
Antineoplastic Agents
/ administration & dosage
Breast Neoplasms
/ drug therapy
Catheterization
/ adverse effects
Catheters, Indwelling
/ adverse effects
Equipment Design
Female
Follow-Up Studies
Humans
Middle Aged
Patient Satisfaction
Preliminary Data
Quality of Life
Retrospective Studies
Superficial Back Muscles
Surveys and Questionnaires
Time Factors
Treatment Outcome
Vascular Access Devices
/ adverse effects
Journal
Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
08
05
2018
revised:
14
08
2018
accepted:
14
08
2018
pubmed:
12
12
2018
medline:
7
5
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
To evaluate the long-term results of and patient satisfaction with trapezius ports in breast cancer patients, as an alternative to chest ports. This retrospective study included all patients who underwent trapezius port placement from December 2007 to January 2017. Seventy female patients with breast cancer, with a mean age of 54 ± 9.9 years (range, 29-76 years), were included. Indications for trapezius implantation were bilateral breast surgery or unilateral breast surgery and contralateral breast involvement. Sixty-eight of 70 patients had long-term follow-up. A retrospective, questionnaire-based survey was conducted to assess satisfaction and the trapezius port's effect on the daily life of the patient. All implantations were technically successful. Total catheter service time for 68 patients was 65,952 days (2 patients were lost to follow-up). Mean catheter service time was 969.8 days (range 7-3,458 days; median 570 days; 95% confidence interval, 739-1199; standard deviation, 947.7). No immediate procedural complications occurred. Port complications developed in 4 patients (5.9%); port infection developed in 2 patients (0.03/1,000 days); skin dehiscence developed in 1 patient (0.02/1,000 days); and port malfunction developed in 1 patient (0.02/1,000 days). The overall infection rate was 2.9% (2/68). All patients (n = 44) or a close relative (n = 17) who were interviewed with a phone call reported satisfaction regarding their ports. Trapezius ports offer a safe and feasible option to patients with breast cancer who need an alternative site to chest ports. It is also associated with high overall patient satisfaction.
Identifiants
pubmed: 30527656
pii: S1051-0443(18)31418-0
doi: 10.1016/j.jvir.2018.08.011
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
69-73Informations de copyright
Copyright © 2018 SIR. Published by Elsevier Inc. All rights reserved.